iBio (IBIO) Shares Outstanding (2010 - 2026)

iBio's (IBIO) quarterly Shares Outstanding (Entity) came in at $125590.0 in Q2 2020, up 211.6% year-on-year from $40305.0 in Q3 2019, and up 169616.22% on a QoQ basis from $74.0 in Q4 2019.

iBio (IBIO) Shares Outstanding (2010 - 2026) Analysis & Trends

iBio (IBIO) has 11 years of Shares Outstanding (Entity) data on file, last reported at $125590.0 in Q2 2020.

  • On a quarterly basis, Shares Outstanding (Entity) rose 211.6% year-over-year to $125590.0 in Q2 2020; TTM through Jun 2020 was $125590.0, a 211.6% increase from a year earlier, with the FY2020 full-year figure at $125590.0, up 211.6% from the prior year.
  • Shares Outstanding (Entity) for Q2 2020 stood at $125590.0, up from $74.0 in the prior quarter.
  • Over the last five years, Shares Outstanding (Entity) for IBIO reached as high as $125590.0 in Q2 2020 and fell as low as $44.0 in Q3 2019.
  • Historically, Shares Outstanding (Entity) has averaged $27722.1 across 5 years, with a median of $18564.0 in 2017.
  • Across the five-year window, Shares Outstanding (Entity) tumbled 99.88% in 2019 and jumped 211.6% in 2020, its largest moves.
  • Year by year, Shares Outstanding (Entity) stood at $17822.0 in 2016, then advanced by 29.41% to $23064.0 in 2017, then jumped by 63.35% to $37674.0 in 2018, then tumbled by 99.8% to $74.0 in 2019, then surged by 169616.22% to $125590.0 in 2020.
  • Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $125590.0 in Q2 2020, $74.0 in Q4 2019, and $44.0 in Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 65,899.61 Bn 65,899.33 Bn - 6,012.74 Bn
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - 47.82 Bn
3 Akari Therapeutics 959.56 Bn 959.56 Bn - 118.76 Bn
4 BeOne Medicines 471.67 Bn 466.88 Bn 1.35 Bn 1.44 Bn
5 Vertex Pharmaceuticals 122.32 Bn 115.07 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 70.04 Bn 61.29 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.06 Bn 62.06 Bn - 400.00 Mn
8 Argenx Se 55.93 Bn 50.74 Bn 1.41 Bn 62.19 Mn
9 Alnylam Pharmaceuticals 37.55 Bn 34.54 Bn 959.66 Mn 132.89 Mn
10 iBio 166.84 Mn 166.84 Mn - 119.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 119.60 Mn
Dec 31, 2025 99.13 Mn
Sep 30, 2025 52.98 Mn
Jun 30, 2025 10.50 Mn
Mar 31, 2025 9.86 Mn
Dec 31, 2024 9.13 Mn
Sep 30, 2024 8.63 Mn
Jun 30, 2024 3.83 Mn
Mar 31, 2024 3.71 Mn
Dec 31, 2023 1.86 Mn
Sep 30, 2023 1.20 Mn
Jun 30, 2023 612,250.00
Mar 31, 2023 659,200.00
Dec 31, 2022 490,350.00
Sep 30, 2022 442,100.00
Jun 30, 2022 436,050.00
Mar 31, 2022 436,192.00
Dec 31, 2021 435,980.00
Sep 30, 2021 435,752.00
Jun 30, 2021 391,240.00